SciClone Pharmaceuticals, Inc.

( )
SCLN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson
PFEPfizer Inc.
ABBVAbbVie, Inc.
MRKMerck & Co., Inc.
BMYBristol-Myers Squibb Company
LLYEli Lilly and Company
NVSNovartis AG Sponsored ADR
AZNAstraZeneca PLC Sponsored ADR
GSKGlaxoSmithKline plc Sponsored ADR
NVONovo Nordisk A/S Sponsored ADR Class B
SNYSanofi Sponsored ADR
LCILannett Company, Inc.
AKTXAkari Therapeutics Plc Sponsored ADR

Company Profile

SciClone Pharmaceuticals, Inc. is a pharmaceutical company. It engages in the development of therapeutics treatment for oncology, infectious diseases and cardiovascular disorders. Its product includes ZADAXIN, Holoxan, Mesna, Endoxan, Farlutal, Methotrexate. Estracyt, DC Bead, Angiomax, Neucardin, Cleviprex, Loramyc, and VIBATIV. The company was founded in 1990 and is headquartered in Foster City, CA.